Amphastar Pharmaceuticals
AMPH
#5798
Rank
โ‚ฌ1.09 B
Marketcap
25,70ย โ‚ฌ
Share price
0.41%
Change (1 day)
16.89%
Change (1 year)

EPS for Amphastar Pharmaceuticals (AMPH)

EPS in 2026 (TTM): 1,50ย โ‚ฌ

According to Amphastar Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 1,58ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,91ย โ‚ฌ a decrease over its 2024 EPS that were of 3,00ย โ‚ฌ.

EPS history for Amphastar Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,50ย โ‚ฌ-21.52%
20251,91ย โ‚ฌ-36.17%
20243,00ย โ‚ฌ15.85%
20232,59ย โ‚ฌ51.87%
20221,70ย โ‚ฌ43.85%
20211,18ย โ‚ฌ3521.88%
20200,03268ย โ‚ฌ-96.55%
20190,95ย โ‚ฌ-900%
2018-0,12ย โ‚ฌ-238.6%
20170,08539ย โ‚ฌ-60.92%
20160,22ย โ‚ฌ
2014-0,23ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tonix Pharmaceuticals
TNXP
-11,78ย โ‚ฌ-843.68%๐Ÿ‡บ๐Ÿ‡ธ USA
SCYNEXIS
SCYX
-4,73ย โ‚ฌ-398.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Marinus Pharmaceuticals
MRNS
-2,13ย โ‚ฌ-234.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-3,52ย โ‚ฌ-322.41%๐Ÿ‡บ๐Ÿ‡ธ USA